+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06033144

Study of Tapia Syndrome Prevalence and Factors in ICU Weaning Unit Patients After Prolonged Orotracheal Intubation

Led by Hopital Forcilles · Updated on 2026-09-23

247

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Tapia syndrome is a rare condition characterized by paralysis of a vocal cord and the same side of the tongue, caused by damage to the recurrent and hypoglossal nerves. This condition leads to difficulties with voice and swallowing. The syndrome is mostly unilateral but can be bilateral, and its exact prevalence and clinical features are not well understood, with fewer than 100 cases reported in medical literature to date. This observational study aims to determine how common Tapia syndrome is among patients admitted to a weaning unit after prolonged orotracheal intubation lasting more than 48 hours. It also seeks to describe the clinical signs such as tongue and soft palate involvement, voice and swallowing impairments, and to identify factors linked with the syndrome. Diagnosis involves clinical tongue examination, nasofibroscopy, and ultrasound. Participants are hospitalized patients in the weaning unit who have undergone long-term intubation and meet specific health criteria. Researchers will assess their neurological and ENT status, perform swallowing tests, and use imaging methods shortly after inclusion. Outcomes measured include the prevalence of Tapia syndrome over about two years, swallowing and voice function, and associated clinical features. The study collects data throughout the participants stay and follow-up period to better understand the condition.

CONDITIONS

Brief Title

Prevalence of Tapia's Syndrome in Weaning Unit

Research Team

E

Estelle ROBIN, SLT

A

Aymeric LE NEINDRE, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here